Required Medical Monitoring
Embarking on ketamine therapy involves rigid safety procedures and time commitments. The administration of Spravato requires a certified medical environment. After receiving the nasal spray, patients are continuously monitored on-site for at least two hours to identify and manage any potential adverse reactions, such as temporary dissociation or elevated blood pressure. Due to these potential effects, patients are forbidden from driving a vehicle until the day following treatment, and only after experiencing a restful sleep. Consequently, Brewster patients must secure a reliable, responsible adult to escort them home after every single visit.
Navigating Hudson Valley Travel
Attending multiple weekly sessions requires diligent travel planning. While Brewster is well-connected, winter snow and ice in the Hudson Valley can quickly disrupt travel schedules, complicating the crucial induction phase of therapy. Telehealth appointments may be utilized for initial psychiatric evaluations and continuous follow-up care, reducing some travel burden. However, telehealth cannot substitute the mandated in-person monitoring required for administering esketamine. Spravato is never administered at home. Furthermore, while some clinicians might prescribe compounded ketamine for home use, this is off-label, and the FDA warns against unsupervised applications without direct, on-site observation. For any acute mental health crisis, immediately contact the 988 Suicide & Crisis Lifeline by calling or texting 988, or dial 911.